Our data support the concept that the selectively increased expression of DEGS1 and ASAH1 in TSC tumor cells leads to increased sphingolipid biosynthesis, which in turn enhances TSC tumor cell viability and growth in preclinical models. Here, DEGS1 is linked to neoplasm.